Spontaneous clinical regression in chronic lymphocytic leukaemia

Summary. Chronic lymphocytic leukaemia (CLL) is a B‐cell disorder, which has a median survival of over 10 years from diagnosis for stage A disease. The natural history of stage A disease is generally indolent or only slowly progressive. It is less well known that CLL may undergo spontaneous regression. We report a series of 10 such cases (eight stage A and two stage B) followed at our institutions.

[1]  M. Bernard,et al.  SPONTANEOUS PHENOTYPIC AND MOLECULAR BLOOD REMISSION IN A CASE OF CHRONIC LYMPHOCYTIC LEUKAEMIA , 1999, British journal of haematology.

[2]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[3]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[4]  E. Kimby,et al.  Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized Trials , 1999 .

[5]  A. Pagliuca.  Strongyloides hyperinfection in adult T‐cell leukaemia/lymphoma , 1999, British journal of haematology.

[6]  Terry J. Hamblin,et al.  Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia , 1999 .

[7]  G. Juliusson,et al.  Cytogenetics in chronic lymphocytic leukemia. , 1998, Seminars in oncology.

[8]  E. Kimby,et al.  Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B-cell disorders. , 1998, Haematologica.

[9]  N. Kay,et al.  Analysis of blood T‐cell cytokine expression in B‐chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL‐4 in resting and activated CD8 T cells , 1997, British journal of haematology.

[10]  S. Chevret,et al.  Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements. , 1992, Leukemia & lymphoma.

[11]  M. Grever,et al.  Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group , 1988, American journal of hematology.

[12]  R. Hoover,et al.  Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism. , 1978, Journal of the National Cancer Institute.